Walter Matthew R. reported option exercise involving 9,149 shares of Medtronic plc at $0.00 for $0 on May 26, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SVP, Chief HR Officer
SVP, Chief HR Officer
Filed May 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
9,149Ordinary Shares
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
41,529Direct
Trade date
May 26, 2026Option exercise
Filed
May 28, 2026, 4:26 PM ET2-day reporting delay
Accession
0002028475-26-000004Code M · Transaction 387659
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 26, 2026Option exercise8,449$0.00$0Trade 387660
2 transaction rows in this filing. Joint filers share the same rows.

MDT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MDT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +10%1w ago +4%1d ago +4%
Returns since7d +8.4%30d +7.2%90d +22%180d1y

Footnotes in full

F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3: The performance share units vested on April 24, 2026.